BILLERICA, Mass.--(BUSINESS WIRE)--Nirrin Technologies, a developer of analytical tools poised to transform bioprocess analysis, has been awarded a $2 million Small Business Innovation Research (SBIR) ...

The use of animal cells, particularly mammalian cells such as CHO, HEK293, CAR-T/-NK, and stem cells, is highly prevalent in various therapeutic biomanufacturing applications, including biologics ...

(MENAFN- iCrowdNewsWire) The business intelligence study details the major trends and developments that surround the Global Next-Generation Biomanufacturing Market and could influence the industry's ...

Industrial biomanufacturing of specialty chemicals across food, cosmetics, pigments, and enzymes. Fermentation-based production. Technology benchmarking and trends in synthetic biology. Market outlook ...

Solugen and ADM formed a strategic partnership to scale a range of plant-based specialty chemicals and bio-based building block molecules in a new manufacturing facility in Marshall, MN. Solugen will ...

As demand for biologics surges, the biopharmaceutical industry is under pressure to increase productivity and flexibility as well as shorten production timelines. At the same time, there is the need ...

Genomic innovation offers opportunities in rapid diagnostics, scalable biomanufacturing, and precision therapies with advances in DNA extraction, pathogen detection, iPSC therapies, and DNA ...

ROCKVILLE, Md., Nov. 19, 2019 /PRNewswire/ -- Researchers at the Institute for Bioscience and Biotechnology Research (IBBR) recently received two awards totaling $1.1M from the Food and Drug ...

Today, 20 March 2024, the European Commission issued an important Communication aimed at boosting biotechnology and biomanufacturing in the EU. These sectors are identified as key strategic areas with ...

Primient, a global leader in biomanufacturing, announced today it has agreed to purchase the remaining ownership interest in Primient Covation, LLC (“Primient Covation”), establishing Primient as the ...

(MENAFN- GlobeNewsWire - Nasdaq) Key market opportunities in the global competent cells market include rising demands in genetic engineering and synthetic biology sectors, driven by advancements in ...